127 related articles for article (PubMed ID: 23619121)
21. Successful treatment of esophageal squamous cell carcinoma in a patient with Fanconi anemia.
Hosoya Y; Lefor A; Hirashima Y; Nokubi M; Yamaguti T; Jinbu Y; Muroi K; Nakazawa M; Yasuda Y
Jpn J Clin Oncol; 2010 Aug; 40(8):805-10. PubMed ID: 20410055
[TBL] [Abstract][Full Text] [Related]
22. IL-2 activated NK cell immunotherapy of three children after haploidentical stem cell transplantation.
Koehl U; Sörensen J; Esser R; Zimmermann S; Grüttner HP; Tonn T; Seidl C; Seifried E; Klingebiel T; Schwabe D
Blood Cells Mol Dis; 2004; 33(3):261-6. PubMed ID: 15528141
[TBL] [Abstract][Full Text] [Related]
23. Germline mutations in BRCA2: shared genetic susceptibility to breast cancer, early onset leukemia, and Fanconi anemia.
Wagner JE; Tolar J; Levran O; Scholl T; Deffenbaugh A; Satagopan J; Ben-Porat L; Mah K; Batish SD; Kutler DI; MacMillan ML; Hanenberg H; Auerbach AD
Blood; 2004 Apr; 103(8):3226-9. PubMed ID: 15070707
[TBL] [Abstract][Full Text] [Related]
24. Wilms tumor, AML, and medulloblastoma in a child with cancer prone syndrome of total premature chromatid separation and Fanconi anemia.
Alter BP; Olson SB
Pediatr Blood Cancer; 2010 Mar; 54(3):488; author reply 489. PubMed ID: 19856400
[No Abstract] [Full Text] [Related]
25. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
Cesaro S; Meloni G; Messina C; Pillon M; Proglia A; Lanino E; Caniggia M; Bagnulo S; Pession A; Locatelli F;
Bone Marrow Transplant; 2001 Jul; 28(2):131-6. PubMed ID: 11509930
[TBL] [Abstract][Full Text] [Related]
26. Is it appropriate to offer allogeneic hematopoietic stem cell transplantation to patients with primary refractory acute myeloid leukemia?
Song KW; Lipton J
Bone Marrow Transplant; 2005 Aug; 36(3):183-91. PubMed ID: 15937497
[TBL] [Abstract][Full Text] [Related]
27. Fanconi anemia: correlating central nervous system malformations and genetic complementation groups.
Johnson-Tesch BA; Gawande RS; Zhang L; MacMillan ML; Nascene DR
Pediatr Radiol; 2017 Jun; 47(7):868-876. PubMed ID: 28283722
[TBL] [Abstract][Full Text] [Related]
28. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia.
Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G
Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430
[TBL] [Abstract][Full Text] [Related]
29. Fanconi's anemia with associated acute nonlymphocytic leukemia.
el Mauhoub M; Sudarshan G; Banerjee G; Aggarwal VP; Shembish N
Indian Pediatr; 1988 Nov; 25(11):1124-7. PubMed ID: 3248883
[No Abstract] [Full Text] [Related]
30. Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.
Talbot A; Peffault de Latour R; Raffoux E; Buchbinder N; Vigouroux S; Milpied N; Leblanc T; Soulier J; Michallet M; Socié G
Haematologica; 2014 Oct; 99(10):e199-200. PubMed ID: 25085358
[No Abstract] [Full Text] [Related]
31. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
[TBL] [Abstract][Full Text] [Related]
32. Targeting DNA repair pathways in AML.
D'Andrea AD
Best Pract Res Clin Haematol; 2010 Dec; 23(4):469-73. PubMed ID: 21130409
[TBL] [Abstract][Full Text] [Related]
33. Immunotherapy with histamine dihydrochloride for the prevention of relapse in acute myeloid leukemia.
Martner A; Thorén FB; Aurelius J; Söderholm J; Brune M; Hellstrand K
Expert Rev Hematol; 2010 Aug; 3(4):381-91. PubMed ID: 21083028
[TBL] [Abstract][Full Text] [Related]
34. Biallelic inactivation of BRCA2 in Fanconi anemia.
Howlett NG; Taniguchi T; Olson S; Cox B; Waisfisz Q; De Die-Smulders C; Persky N; Grompe M; Joenje H; Pals G; Ikeda H; Fox EA; D'Andrea AD
Science; 2002 Jul; 297(5581):606-9. PubMed ID: 12065746
[TBL] [Abstract][Full Text] [Related]
35. Sorafenib induces sustained molecular remission in FLT3-ITD positive AML with relapse after second allogeneic stem cell transplantation without exacerbation of acute GVHD: a case report.
Winkler J; Rech D; Kallert S; Rech J; Meidenbauer N; Roesler W; Mackensen A
Leuk Res; 2010 Oct; 34(10):e270-2. PubMed ID: 20627386
[No Abstract] [Full Text] [Related]
36. Fanconi anemia is a highly penetrant cancer susceptibility syndrome.
Dokal I
Haematologica; 2008 Apr; 93(4):486-8. PubMed ID: 18379006
[No Abstract] [Full Text] [Related]
37. The association between FANCD1/BRCA2 mutations and leukaemia.
Alter BP
Br J Haematol; 2006 May; 133(4):446-8; author reply 448. PubMed ID: 16643458
[No Abstract] [Full Text] [Related]
38. [Allogenic transplantation of hematopoietic stem cells in the treatment of children with high-risk acute leukemia].
Starý J; Kobylka P; Sedlácek P; Komrska V; Vávra V; Syrůcková Z; Smísek P; Hrubá A; Korínková P; Matĕjková E; Cukrová V; Dolezalová L; Loudová M; Sejkorová J; Kvĕch J
Cas Lek Cesk; 1998 Jun; 137(12):363-7. PubMed ID: 9721472
[TBL] [Abstract][Full Text] [Related]
39. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.
Margolin K; Forman SJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S33-8. PubMed ID: 10685656
[TBL] [Abstract][Full Text] [Related]
40. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
